Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs PR 15 (Primary)
- Indications Carotid stenosis; Embolism and thrombosis; Stroke; Transient ischaemic attacks
- Focus Therapeutic Use
- Sponsors advanceCor
- 17 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 17 Jan 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
- 15 Sep 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2017 as reported by ClinicalTrials.gov record.